CLINICAL RESULTS OF THROMBOLYTIC THERAPY WITH ALTEPLASE AND TENECTEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION

Show other versions (1)

Aim. To evaluate the clinical results of thrombolytic therapy with thrombolytics (alteplase, tenecteplase) in patients with ST segment elevation myocardial infarction (STEMI). Material and methods. Patients with STEMI (n=181) included in the study were split into two groups depending on the thrombol...

Full description

Bibliographic Details
Published in:	Рациональная фармакотерапия в кардиологии
Main Authors:	L. A. Bondarenko, L. E. Rudakova, F. K. Rakhmatullov, T. P. Kostrikova, I. I. Kapustina
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-12-01
Subjects:	st segment elevation myocardial infarction thrombolysis alteplase tenecteplase
Online Access:	https://www.rpcardio.online/jour/article/view/583

Similar Items

THE RELEVANCE OF THROMBOLYTIC THERAPY IN ST ELEVATION MYOCARDIAL INFARCTION
by: N. V. Teplova, et al.
Published: (2014-05-01)

Replacing Alteplase with Tenecteplase: Is the Time Ripe?
by: Nishita Singh, et al.
Published: (2023-01-01)

Feasibility of switching from alteplase to tenecteplase for stroke thrombolysis – A retrospective cohort analysis
by: Vilhelm Sjögren, et al.
Published: (2023-06-01)

Comparative Analysis of Tenecteplase versus Alteplase in Acute Ischemic Stroke: A Multicentric Observational Study from Eastern India
by: Arpan Dutta, et al.
Published: (2024-05-01)

Tenecteplase compared to alteplase in real-world outcome: A Swedish Stroke Register study
by: Mikael Skärlund, et al.
Published: (2024-10-01)

Tenecteplase is here: navigating the shift of a stroke thrombolytic in the United States prior to FDA approval: a mini-review on rationale, barriers, and pathways
by: Julian M. Burwell, et al.
Published: (2025-04-01)

CLINICAL RESULTS OF THROMBOLYTIC THERAPY WITH ALTEPLASE AND TENECTEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION
by: L. A. Bondarenko, et al.
Published: (2015-12-01)

COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE
by: V. V. Omel'yanovskiy, et al.
Published: (2016-01-01)

Comprehensive Review of Tenecteplase for Thrombolysis in Acute Ischemic Stroke
by: Liyuan Wang, et al.
Published: (2024-05-01)

Tenecteplase and alteplase for thrombolysis of acute ischemic stroke within 4.5 hours: An efficacy and safety study
by: Nikita Dhar, et al.
Published: (2022-01-01)

Comparative effectiveness and safety of tenecteplase versus alteplase for intravenous thrombolysis in acute ischemic stroke: a retrospective study
by: Weili Zhao, et al.
Published: (2025-10-01)

Preintensive care: Thrombolytic (streptokinase or tenecteplase) in ST elevated acute myocardial infarction at peripheral hospital
by: Himmatrao S Bawaskar, et al.
Published: (2019-01-01)

Safety and efficacy of streptokinase, tenecteplase, and reteplase in patients diagnosed with ST-elevation myocardial infarction: A comparative study
by: Bhargavi Neela, et al.
Published: (2020-01-01)

Evaluating the Safety of Tenecteplase Versus Alteplase for Acute Ischemic Stroke
by: Salma Guerrero Miranda, et al.
Published: (2025-08-01)

Use of thrombolytic agents for ST-elevation myocardial infarction care in India: An expert consensus
by: Arun Chopra, et al.
Published: (2021-01-01)

RISKS AND BENEFITS OF REPERFUSION STRATEGIES IN ACUTE MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATION
by: T. M. Poponina, et al.
Published: (2010-10-01)

THROMBOLYTIC THERAPY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
by: E. V. Konstantinova, et al.
Published: (2016-01-01)

Safety of tenecteplase vs. alteplase in telestroke: a large multistate experience (STAT)
by: Morgan Figurelle, et al.
Published: (2025-01-01)

Clinical effectiveness of thrombolytic therapy with alteplase and double antiplatelet therapy in acute myocardial infarction
by: D. N. Kuznetsov, et al.
Published: (2011-12-01)

Alteplase vs. Tenecteplase: An In-depth Analysis of Their Relative Effectiveness in Treating Acute Ischemic Stroke
by: Muhammad Junaid Azhar, et al.
Published: (2024-10-01)

Tenecteplase vs. Alteplase for Intravenous Thrombolytic Therapy of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
by: Ziyi Shen, et al.
Published: (2023-08-01)

Tenecteplase versus alteplase for the treatment of acute ischemic stroke: a meta-analysis of randomized controlled trials
by: Jian Huang, et al.
Published: (2024-12-01)

Tenecteplase versus alteplase in patients with acute ischemic stroke: an updated systematic review and meta-analysis
by: Abdelmonam M. Hagag, et al.
Published: (2025-08-01)

Primary angioplasty and pharmaco-invasive strategies in the treatment of ST-elevated myocardial infarction
by: M. G. Glezer, et al.
Published: (2019-04-01)

Efficacy and Safety of Intravenous Tenecteplase Versus Alteplase in Treating Acute Ischemic Stroke With Diabetes and Admission Hyperglycemia
by: Huihui Liu, et al.
Published: (2024-10-01)

Tenecteplase Versus Alteplase in Medium Vessel Occlusion Ischemic Stroke: A Secondary Analysis of the Alteplase Compared to Tenecteplase Randomized Trial
by: Fouzi Bala, et al.
Published: (2024-05-01)

Tenecteplase vs. alteplase for treatment of acute ischemic stroke: A systematic review and meta-analysis of randomized trials
by: Hassan Kobeissi, et al.
Published: (2023-01-01)

Implementation of a Tenecteplase Protocol for Treatment of Acute Ischemic Stroke in a Health System
by: Alexis Pace, et al.
Published: (2024-04-01)

Post Thrombolytic St-Segment Resolution Outcome in Acute Myocardial Infarction Patients
by: Aamir Ahmad, et al.
Published: (2022-04-01)

COMPARATIVE RESULTS OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE AND TENECTEPLASE USE IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN REAL CLINICAL PRACTICE
by: E. S. Mazur, et al.
Published: (2017-09-01)

Selection of P2Y12 antagonist in patients with myocardial infarction who received thrombolytic therapy. Results of annual follow-up of TREAT study patients
by: O. V. Averkov, et al.
Published: (2019-09-01)

Tenecteplase Versus Alteplase in Acute Ischemic Stroke in Chinese Patients: Protocol for the ORIGINAL Study
by: Xia Meng, et al.
Published: (2024-07-01)

N-terminal pro-B-type natriuretic peptide as a predictive marker of the outcomes of fibrinolytic therapy in acute ST-elevation myocardial infarction
by: Amit Kumar, et al.
Published: (2024-04-01)

In Silico Study of Different Thrombolytic Agents for Fibrinolysis in Acute Ischemic Stroke
by: Yilin Yang, et al.
Published: (2023-02-01)

A study on clinical profile and in-hospital outcome of elderly patients receiving thrombolytic therapy for ST elevation myocardial infarction
by: Darshan P Thakkar, et al.
Published: (2022-01-01)

Tenecteplase vs alteplase as bridging thrombectomy in ischemic stroke patients: a systematic review and meta analysis
by: Salim Harris, et al.
Published: (2025-08-01)

Real-world data of tenecteplase vs. alteplase in the treatment of acute ischemic stroke: a single-center analysis
by: Yu Yao, et al.
Published: (2024-04-01)

Switch to tenecteplase for intravenous thrombolysis in stroke patients: experience from a German high-volume stroke center
by: Alexander Sekita, et al.
Published: (2025-05-01)

Tenecteplase versus alteplase for intravenous thrombolysis of acute ischemic stroke patients with large-vessel occlusion: a systematic review and meta-analysis
by: Beibei Yao, et al.
Published: (2025-03-01)

Risk of angioedema and thrombolytic therapy among stroke patients: An analysis of data from the FDA Adverse Event Reporting System database
by: Hunong Xiang, et al.
Published: (2025-01-01)